Description:
The in vitro diagnostics (IVD) market is a global multi-billion-dollar industry, with significant revenue generated outside the United States. To facilitate successful business planning, it’s crucial to assess regional and country-level IVD markets. Kalorama’s 30 Country IVD Market Atlas report offers detailed insights into international markets, aiding in forecast modeling and strategic planning.
Key Features:
- Comprehensive coverage of 30 countries, including Latin America, the Middle East, APAC, and Eastern Europe
- Reliable estimates from an IVD-focused analyst team, authors of Kalorama’s renowned Worldwide Market for In Vitro Diagnostics report
- Sizing for 19 important IVD market segments, including lab-based and point-of-care (POC) segments for various disease areas
- Forecasts in revenue up to 2028 for each segment, with compound annual growth rates (CAGRs) provided
- Quarterly updates (4 annually in 2023) to reflect market changes, ensuring the latest data for informed decision-making
- Analyst notes highlighting significant developments in the industry
- Definitions and descriptions of tests for better understanding
- Over 2800 data points offering comprehensive market insights
Why Choose the IVD Market Atlas:
- One report covering 30 countries, saving the need to purchase multiple individual country reports
- Aligned with Kalorama’s expert global estimates, providing consistent and reliable market data
- Includes major IVD segments forecasted over five years, offering a holistic view of the market
Market Segments Covered:
- Blood Bank Immunoassays
- Blood Bank Molecular (NAT)
- Clinical Chemistry
- Coagulation
- COVID-19
- Critical Care
- FOB
- Glucose
- Hematology
- Histology/Cytology
- ID/AST Microbiology
- Immunoassays
- Immunoassays, Micro
- Molecular, Micro
- Molecular, Others
- Overall Country IVD
- Point of Care
- POC Infectious Disease
- Pregnancy Testing
Subscribe for Quarterly Updates:
Subscribers will receive quarterly updates via Kalorama’s Knowledge Center product, ensuring they always have the latest data for their business planning needs. Stay ahead of market changes and make informed decisions with Kalorama’s 30 Country IVD Market Atlas.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: Japan IVD Market by Segment, Estimated 2023-2028 (in millions $)
| Segment | 2023 | 2028 | CAGR |
| General Chemistries | $XX Million | $XX Million | XX% |
| Critical Care (core lab) | $XX Million | $XX Million | XX% |
| Hematology | $XX Million | $XX Million | XX% |
| Coagulation PT/Routine | $XX Million | $XX Million | XX% |
| Immunoassays – Micro | $XX Million | $XX Million | XX% |
| Immunoassays – Non-Micro | $XX Million | $XX Million | XX% |
| Blood Bank Screening – Immunos | $XX Million | $XX Million | XX% |
| Microbiology – ID/AST | $XX Million | $XX Million | XX% |
| Molecular Respiratory | $XX Million | $XX Million | XX% |
| Molecular Bloodstream/HAI | $XX Million | $XX Million | XX% |
| Molecular HIV & Hepatitis | $XX Million | $XX Million | XX% |
| Molecular – Other (blood screening, STDs, and other microbiology) | $XX Million | $XX Million | XX% |
| POC Glucose (all) | $XX Million | $XX Million | XX% |
| POC Critical Care | $XX Million | $XX Million | XX% |
| POC Infectious Disease (all) | $XX Million | $XX Million | XX% |
| POC Pregnancy & Fertility | $XX Million | $XX Million | XX% |
| POC Fecal Occult | $XX Million | $XX Million | XX% |
| Other POC | $XX Million | $XX Million | XX% |
| Histology | $XX Million | $XX Million | XX% |
| Other IVD | $XX Million | $XX Million | XX% |
| Total Japan IVD Market | $XX Million | $XX Million | XX% |
| SARS-Cov-2 (COVID-19) Market* | $XX Million | $XX Million | XX% |
*Extracted from Immunoassay, Molecular and POC Infectious Disease Markets
Source: Kalorama Information
